The Filing Desk

Cerus vs Orthopediatrics

Cerus CERS · Orthopediatrics KIDS · Health Care Equipment

Orthopediatrics reported revenue of $236 million in fiscal 2025, about the same as Cerus' $234 million in fiscal 2025. Cerus' revenue grew 16.1% in its latest year, and Orthopediatrics' grew 15.4%. Cerus had an operating margin of -3.7%, against -16.6% at Orthopediatrics. Free cash flow was $1 million at Cerus and −$16 million at Orthopediatrics.

Side by side

CerusOrthopediatrics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$234M$236M
Revenue growth16.1%15.4%
Revenue growth a year, last 5 years15.4%27.2%
Gross margin—73.0%
Operating margin−3.7%−16.6%
Net margin−6.7%−16.8%
Free cash flow$1M−$16M
Free cash flow margin0.5%−6.8%
Return on capital—−8.2%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count3.3%1.6%
Last close$1.99$32.35
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—4 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CerusOrthopediatrics
Operating margin
Percent of revenue
CerusOrthopediatrics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CerusOrthopediatrics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cerus and Orthopediatrics pages.